Concordantly, HIF2α-activating mutations in humans have been associated with either polycythemia, a condition of elevated hematocrit, or neuroendocrine tumours, including paraganglioma, pheochromocytoma, and somatostatinoma41,50. The gene discussed is EPAS1; the disease is hereditary pheochromocytoma-paraganglioma.